<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01817088</url>
  </required_header>
  <id_info>
    <org_study_id>CHUBX 2012/07</org_study_id>
    <nct_id>NCT01817088</nct_id>
  </id_info>
  <brief_title>Sub-thalamic Nucleus Stimulation in Parkinson Disease</brief_title>
  <acronym>PARKEO</acronym>
  <official_title>Sub-thalamic Nucleus Stimulation in Parkinson Disease: Comparison of a Two-steps Electrophysiological Approach Under Local and General Anesthesia and a One-step Approach Under General Anesthesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Bordeaux</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Bordeaux</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Deep brain stimulation (DBS) is an established procedure for the symptomatic treatment of
      Parkinson's disease. This procedure performed in two steps using electrophysiology. This
      study is a prospective, randomized and monocentric study to compare two DBS procedures with
      or without electrophysiology.

      A better control of targeting and trajectory is necessary before not using electrophysiology,
      which is the reference procedure. A new definition of sub thalamic nuclei with new MRI
      stereotactic landmarks, the use of surgical robot (Neuromata Renishaw) and the use of
      operative imaging (O-arm) could allow the implantation of electrode in sub-thalamic nuclei
      without the need of electrophysiology.

      Two groups of patients will be followed: a first group of patients with a procedure under
      general anesthesia alone without electrophysiological stimulation and a second smaller group
      of patients with a first step of electrode implantation under awake surgery with
      electrophysiological stimulation followed by a second step under general anesthesia for the
      implantation of stimulator.

      Clinical results will be assessed at 6 months after implantation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Deep brain stimulation (DBS) is an established procedure for the symptomatic treatment of
      Parkinson's disease. This procedure performed in two steps using electrophysiology (Limousin
      et al., 1995) to register the activity of the sub-thalamic nucleus and test the efficacy of
      stimulation while the patient is awake. A second procedure is needed a few days later to
      implant the stimulation device under general anaesthesia. The duration of the first procedure
      is long because of a necessary time of deep stimulation to control the target before
      definitive implantation. Firstly, the long time of procedure causes pain for the patient.
      Secondly, the time of procedure, and thus of electrophysiology, is correlated with a rate of
      device infection of 5 % - 6 % (Hamani et al., 2006; Kenney et al., 2007; Sillay et al., 2008;
      Doshi et al., 2011). Thirdly, the introduction of several microelectrodes increases the risk
      of operative and postoperative haemorrhages, estimated at 1 % (Kenney et al., 2007; Sansur et
      al., 2007; Voges et al., 2007; Bhatia et al., 2008). Moreover, Foltynie et al. (2011)
      described 12/79 patients treated under general anaesthesia alone with the same post operative
      results than those who were firstly treated under local anaesthesia.

      A better control of targeting and trajectory is necessary before not using electrophysiology,
      which is the reference procedure. A new definition of sub thalamic nuclei with new MRI
      stereotactic landmarks, the use of surgical robot (Neuromata Renishaw) and the use of
      operative imaging (O-arm) could allow the implantation of electrode in sub-thalamic nuclei
      without the need of electrophysiology. (Caire et al. 2012, In press).

      This study is a prospective, randomized and monocentric study. The randomization will be made
      according to a ratio 2:1 in favour of the technique without electrophysiology. Two groups of
      patients will be followed: a first group of patients with a procedure under general
      anesthesia alone without electrophysiological stimulation and a second smaller group of
      patients with a first step of electrode implantation under awake surgery with
      electrophysiological stimulation followed by a second step under general anesthesia.

      After a preoperative assessment, a end-point evaluation at 6 months after implantation will
      complete the follow-up.

      The stimulation efficacy (UPDRS-3) and the post operative adverse effects will be noticed.

      This study will also evaluate the occurrence of a post-traumatic stress disorder (PTSD) in
      Parkinson disease patients operated under deep brain stimulation.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 11, 2013</start_date>
  <completion_date type="Actual">September 9, 2016</completion_date>
  <primary_completion_date type="Actual">September 9, 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the ratio of preoperative and postoperative UPDRS 3 score</measure>
    <time_frame>6 month</time_frame>
    <description>The primary outcome is defined after six months of sub-thalamic nucleus deep brain stimulation with the ratio of preoperative and postoperative UPDRS 3 score. The ratio is : (post operative UPDRS 3 OFF medicine and OFF stimulation- post operative UPDRS 3 OFF medicine ON stimulation)/(post operative UPDRS 3 OFF medicine OFF stimulation)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Stimulation efficacy</measure>
    <time_frame>6 month</time_frame>
    <description>Efficacy with the ratio : (Preoperative UPDRS 3 OFF medicine - post operative UPDRS 3 OFF medicine ON stimulation)/( preoperative UPDRS 3 OFF medicine )</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The variance of improvement mean for the &quot;high precision&quot; technique</measure>
    <time_frame>6 month</time_frame>
    <description>The variance of improvement mean for the &quot;high precision&quot; technique</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of patients with an improvement of UPDRS III score</measure>
    <time_frame>6 month</time_frame>
    <description>Percentage of patients with an improvement of UPDRS III score of 35%, 50% et 65%</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Calculated preoperative and post operative (6 months) equivalent dose of L-DOPA and the decrease of between preoperative and post operative period (6 months).</measure>
    <time_frame>6 month</time_frame>
    <description>The Calculated preoperative and post operative (6 months) equivalent dose of L-DOPA and the decrease of between preoperative and post operative period (6 months).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of patients with failure of the new surgical technique defined with an improvement of less than 35 % with the UPDRS 3 score and an electrode located more than 4 mm from the target</measure>
    <time_frame>6 month</time_frame>
    <description>Percentage of patients with failure of the new surgical technique defined with an improvement of less than 35 % with the UPDRS 3 score and an electrode located more than 4 mm from the target</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life</measure>
    <time_frame>6 month</time_frame>
    <description>Quality of Life scale : PDQ-39</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Non motor items of UPDRS score in the high precision technique under general anesthesia alone</measure>
    <time_frame>6 month</time_frame>
    <description>Non motor items of UPDRS score in the high precision technique under general anesthesia alone</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse effects and complications</measure>
    <time_frame>6 month</time_frame>
    <description>Adverse effects and complications : infection, haemorrhages, paresthesia, hypophonia and dyskinesia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of improvement in patients with the reference technique</measure>
    <time_frame>6 month</time_frame>
    <description>Percentage of improvement in patients with the reference technique (electrophysiological approach in awake surgery)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Compare the technical feasibility for both surgeries based on the number of electrodes implanted in the target</measure>
    <time_frame>after surgery</time_frame>
    <description>Compare the technical feasibility for both surgeries based on the number of electrodes implanted in the target</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Operative and postoperative surgical adverse effects.</measure>
    <time_frame>6 month</time_frame>
    <description>Operative and postoperative surgical adverse effects.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluate the influence of two operative procedures on the onset and maintenance of post-operative PTSD</measure>
    <time_frame>6 month</time_frame>
    <description>Evaluate the influence of two operative procedures on the onset and maintenance of post-operative PTSD</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluate the influence of two operative procedures on the level of preoperative anxiety and the time course of this anxiety</measure>
    <time_frame>1, 3 and 6 month</time_frame>
    <description>Evaluate the influence of two operative procedures on the level of preoperative anxiety and the time course of this anxiety</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Differentiate thymic and cognitive factors potentially predictors of the occurrence of post-surgical PTSD</measure>
    <time_frame>6 month</time_frame>
    <description>Differentiate thymic and cognitive factors potentially predictors of the occurrence of post-surgical PTSD</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluate the long-term effects of the two operating procedures on thymic and cognitive state</measure>
    <time_frame>6 month</time_frame>
    <description>Evaluate the long-term effects of the two operating procedures on thymic and cognitive state</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluate the dose of irradiation received by patients during surgery in both procedures</measure>
    <time_frame>During surgery</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Parkinson's Disease</condition>
  <arm_group>
    <arm_group_label>New targeting procedure without electrophysiology</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients with the high precision procedure under general anesthesia alone without electrophysiological stimulation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Classical neurosurgical procedure</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patients with a first step of electrode implantation under awake surgery with electrophysiological control followed by a second step under general anesthesia</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>New targeting procedure without electrophysiology</intervention_name>
    <description>It is a neurosurgical procedure of electrodes implantation in the sub thalamic nuclei under general anaesthesia using a new targeting procedure without electrophysiology.</description>
    <arm_group_label>New targeting procedure without electrophysiology</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Classical neurosurgical procedure</intervention_name>
    <description>It is a neurosurgical procedure of electrodes implantation in the sub thalamic nuclei under awake surgery with electrophysiological control. A second surgical step is performed to implant the subcutaneous stimulation device, under general anesthesia.</description>
    <arm_group_label>Classical neurosurgical procedure</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age : between 18 and 70 years old

          -  Parkinson disease in fluctuation state despite the use of an optimal medical treatment

          -  Dopa sensibility higher than 50% with the L-DOPA test

          -  Normal MRI

          -  Mattis Scale &gt; 130

          -  Surgical indication approved by a multidisciplinary team

          -  Patient covered by a social insurance

          -  Informed consent signed by patient and investigator

        Exclusion Criteria:

          -  Patients with surgical or anesthetic contraindications

          -  Cerebral atrophy or signal abnormalities on MRI

          -  Severe Depressive State : The Beck Scale score &gt; 15

          -  Women of childbearing potential without efficient contraceptive mean

          -  Need of long-term antithrombotic treatment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Emmanuel CUNY, MD-PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Bordeaux, France</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Antoine BENARD, MD</last_name>
    <role>Study Chair</role>
    <affiliation>University Hospital Bordeaux, France</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital</name>
      <address>
        <city>Bordeaux</city>
        <zip>33076</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Bronstein JM, Tagliati M, Alterman RL, Lozano AM, Volkmann J, Stefani A, Horak FB, Okun MS, Foote KD, Krack P, Pahwa R, Henderson JM, Hariz MI, Bakay RA, Rezai A, Marks WJ Jr, Moro E, Vitek JL, Weaver FM, Gross RE, DeLong MR. Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues. Arch Neurol. 2011 Feb;68(2):165. doi: 10.1001/archneurol.2010.260. Epub 2010 Oct 11. Review.</citation>
    <PMID>20937936</PMID>
  </reference>
  <reference>
    <citation>Cuny E, Guehl D, Burbaud P, Gross C, Dousset V, Rougier A. Lack of agreement between direct magnetic resonance imaging and statistical determination of a subthalamic target: the role of electrophysiological guidance. J Neurosurg. 2002 Sep;97(3):591-7.</citation>
    <PMID>12296643</PMID>
  </reference>
  <reference>
    <citation>Ferrara J, Diamond A, Hunter C, Davidson A, Almaguer M, Jankovic J. Impact of STN-DBS on life and health satisfaction in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry. 2010 Mar;81(3):315-9. doi: 10.1136/jnnp.2009.184127. Epub 2009 Sep 1.</citation>
    <PMID>19726415</PMID>
  </reference>
  <reference>
    <citation>Kenney C, Simpson R, Hunter C, Ondo W, Almaguer M, Davidson A, Jankovic J. Short-term and long-term safety of deep brain stimulation in the treatment of movement disorders. J Neurosurg. 2007 Apr;106(4):621-5.</citation>
    <PMID>17432713</PMID>
  </reference>
  <reference>
    <citation>Kleiner-Fisman G, Herzog J, Fisman DN, Tamma F, Lyons KE, Pahwa R, Lang AE, Deuschl G. Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Mov Disord. 2006 Jun;21 Suppl 14:S290-304. Review.</citation>
    <PMID>16892449</PMID>
  </reference>
  <reference>
    <citation>Limousin P, Krack P, Pollak P, Benazzouz A, Ardouin C, Hoffmann D, Benabid AL. Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med. 1998 Oct 15;339(16):1105-11.</citation>
    <PMID>9770557</PMID>
  </reference>
  <reference>
    <citation>MaltÃªte D, Navarro S, Welter ML, Roche S, Bonnet AM, Houeto JL, Mesnage V, Pidoux B, Dormont D, Cornu P, Agid Y. Subthalamic stimulation in Parkinson disease: with or without anesthesia? Arch Neurol. 2004 Mar;61(3):390-2.</citation>
    <PMID>15023817</PMID>
  </reference>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 20, 2013</study_first_submitted>
  <study_first_submitted_qc>March 20, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 22, 2013</study_first_posted>
  <last_update_submitted>August 22, 2017</last_update_submitted>
  <last_update_submitted_qc>August 22, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 24, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Deep Brain Stimulation (DBS)</keyword>
  <keyword>Parkinson disease</keyword>
  <keyword>Stereotaxis Technique</keyword>
  <keyword>Subthalamic nucleus</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

